MIRM R&D to Revenue
Mirum Pharmaceuticals Inc · R&D to Revenue
MIRM R&D to Revenue
Latest reported51.37%period ending
MIRM Quarterly R&D/Revenue (0.00% → 51.37%)
Latest values, visible window
High-resolution chart · PNG
MIRM r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 51.3654% | |
| 61.2389% | |
| 34.3157% | |
| 32.2983% | |
| 36.0504% | |
| 41.2636% | |
| 44.2855% | |
| 35.0864% | |
| 41.9544% | |
| 46.5488% | |
| 44.4762% | |
| 54.7239% | |
| 58.6954% | |
| 74.5237% | |
| 111.4635% | |
| 139.6006% | |
| 145.4587% | |
| 186.8446% | |
| 885.1179% | |
| 609.42% | |
| 318.6182% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |